Cargando…

Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1

Infections caused by human immunodeficiency virus (HIV) are considered one of the main public health problems worldwide. Antiretroviral therapy (ART) is the current modality of treatment for HIV-1 infection. It comprises the combined use of several drugs and can decrease the viral load and increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serna-Arbeláez, Maria S., Florez-Sampedro, Laura, Orozco, Lina P., Ramírez, Katherin, Galeano, Elkin, Zapata, Wildeman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181102/ https://www.ncbi.nlm.nih.gov/pubmed/34194504 http://dx.doi.org/10.1155/2021/5552088

Ejemplares similares

In Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine against Human Immunodeficiency Virus 1 (HIV-1)
por: Serna-Arbeláez, Maria S., et al.
Publicado: (2023)

Development of an optimized method for processing peripheral blood mononuclear cells for (1)H-nuclear magnetic resonance-based metabolomic profiling
por: Gómez-Archila, León Gabriel, et al.
Publicado: (2021)

Seronegative MSM at high risk of HIV-1 acquisition show an immune quiescent profile with a normal immune response against common antigens
por: Ossa-Giraldo, Ana C., et al.
Publicado: (2022)

Plasma metabolomics by nuclear magnetic resonance reveals biomarkers and metabolic pathways associated with the control of HIV-1 infection/progression
por: Gómez-Archila, León Gabriel, et al.
Publicado: (2023)

NK Cell Activity and CD57(+)/NKG2C(high) Phenotype Are Increased in Men Who Have Sex With Men at High Risk for HIV
por: Flórez-Álvarez, Lizdany, et al.
Publicado: (2020)

High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus
por: Gonzalez, Sandra Milena, et al.
Publicado: (2015)

In Vitro and In Silico Anti-Arboviral Activities of Dihalogenated Phenolic Derivates of L-Tyrosine
por: Loaiza-Cano, Vanessa, et al.
Publicado: (2021)

NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies
por: Flórez-Álvarez, Lizdany, et al.
Publicado: (2018)

Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection
por: Taborda-Vanegas, Natalia, et al.
Publicado: (2011)

Inhibitory Activity of Marine Sponge-Derived Natural Products against Parasitic Protozoa
por: Orhan, Ilkay, et al.
Publicado: (2010)

Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis
por: Singh, Sheo B., et al.
Publicado: (2018)

Ramsay Hunt Syndrome with Multiple Cranial Neuropathy in an Human Immunodeficiency Virus (HIV) Patient
por: Arya, Divya, et al.
Publicado: (2018)

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
por: Yu, Danwei, et al.
Publicado: (2021)

In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
por: Zapata-Cardona, Maria I., et al.
Publicado: (2023)

Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against Leishmania tarentolae In Vitro
por: Zaman, Shariq M., et al.
Publicado: (2023)

The Hydroalcoholic Extract of Uncaria tomentosa (Cat's Claw) Inhibits the Infection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In Vitro
por: Yepes-Perez, Andres F., et al.
Publicado: (2021)

Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus
por: Hartmann, Katrin, et al.
Publicado: (2015)

Multiple Myeloma Inhibitory Activity of Plant Natural Products
por: Jöhrer, Karin, et al.
Publicado: (2021)

NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity
por: Rincón, Daniel S., et al.
Publicado: (2023)

Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
por: Marín-Palma, Damariz, et al.
Publicado: (2021)

Defective natural immunity: an early manifestation of human immunodeficiency virus infection
Publicado: (1995)

Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom
por: Samman, A., et al.
Publicado: (2011)

Natural transmission of feline immunodeficiency virus from infected queen to kitten
por: Medeiros, Sheila de Oliveira, et al.
Publicado: (2012)

Feline immunodeficiency virus (FIV) env recombinants are common in natural infections
por: Bęczkowski, Paweł M, et al.
Publicado: (2014)

Antiviral Activity Exerted by Natural Products against Human Viruses
por: Musarra-Pizzo, Maria, et al.
Publicado: (2021)

Semiparametric Modeling of Daily Ammonia Levels in Naturally Ventilated Caged-Egg Facilities
por: Gutiérrez-Zapata, Diana María, et al.
Publicado: (2016)

Role of Active and Inactive Cytotoxic Immune Response in Human Immunodeficiency Virus Dynamics
por: Toro Zapata, Hernan Dario, et al.
Publicado: (2014)

Zelkovamycin is an OXPHOS Inhibitory Member of the Argyrin Natural Product Family
por: Krahn, Daniel, et al.
Publicado: (2020)

Marine natural products with monoamine oxidase (MAO) inhibitory activity
por: Hong, Ahreum, et al.
Publicado: (2020)

Primary Gastrointestinal Kaposi's Sarcoma in a Patient with Human Immunodeficiency Virus
por: Zapata Laguado, Martin Ignacio, et al.
Publicado: (2018)

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia
por: Camargo, Milena, et al.
Publicado: (2014)

Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides
por: Schafer, Jamie L., et al.
Publicado: (2015)

Assessment of the gorilla gut virome in association with natural simian immunodeficiency virus infection
por: D’arc, Mirela, et al.
Publicado: (2018)

Pathological features of lymphoid tissues in cats with natural feline immunodeficiency virus infection
por: Brown, P.J., et al.
Publicado: (1991)

Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus–associated Tuberculosis
por: Walker, Naomi F, et al.
Publicado: (2020)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

In Vitro Growth Inhibitory Activities of Natural Products from Irciniid Sponges against Cancer Cells: A Comparative Study
por: BenRedjem Romdhane, Yosr, et al.
Publicado: (2016)

Effect of dual-subtype vaccine against feline immunodeficiency virus infection
por: Hohdatsu, Tsutomu, et al.
Publicado: (1997)

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo
por: Poirier, Miriam C, et al.
Publicado: (2009)

Animal immunodeficiency viruses
por: Egberink, H., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_5chun0qnm8f60iubp6o89i62kk